Correlation Between Pfizer and Vior
Can any of the company-specific risk be diversified away by investing in both Pfizer and Vior at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Vior into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Vior Inc, you can compare the effects of market volatilities on Pfizer and Vior and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Vior. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Vior.
Diversification Opportunities for Pfizer and Vior
Modest diversification
The 3 months correlation between Pfizer and Vior is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Vior Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vior Inc and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Vior. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vior Inc has no effect on the direction of Pfizer i.e., Pfizer and Vior go up and down completely randomly.
Pair Corralation between Pfizer and Vior
Considering the 90-day investment horizon Pfizer Inc is expected to generate 0.26 times more return on investment than Vior. However, Pfizer Inc is 3.83 times less risky than Vior. It trades about -0.05 of its potential returns per unit of risk. Vior Inc is currently generating about -0.09 per unit of risk. If you would invest 2,599 in Pfizer Inc on December 28, 2024 and sell it today you would lose (98.00) from holding Pfizer Inc or give up 3.77% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 96.77% |
Values | Daily Returns |
Pfizer Inc vs. Vior Inc
Performance |
Timeline |
Pfizer Inc |
Vior Inc |
Pfizer and Vior Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pfizer and Vior
The main advantage of trading using opposite Pfizer and Vior positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Vior can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vior will offset losses from the drop in Vior's long position.Pfizer vs. Emergent Biosolutions | Pfizer vs. Bausch Health Companies | Pfizer vs. Neurocrine Biosciences | Pfizer vs. Teva Pharma Industries |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |